Skip to main content

Table 3 Demonstration of CHIKV IgG in CSF of Neuro-CHIKV and Non-CHIKV group by ELISA method.

From: Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications

Study Subjects Positivity for IgG (%) Negativity for IgG (%)
Neuro-CHIKV patients (n = 46) 29 (63%) 17 (37%)
Confirmed (n = 9) 5 (56%) 4 (44%)
   Encephalitis (n = 4) 1 (25%) 3 (75%)
   Myelopathy (n = 2) 1 (50%) 1 (50%)
   Myeloneuropathy (n = 1) 1 (100%) 0
   Peripheral Neuropathy (n = 1) 1 (100%) 0
   Myopathy (n = 1) 1 (100%) 0
Suspected (n = 37) 24 (65%) 13 (35%)
   Encephalitis (n = 20) 15 (75%) 5 (25%)
   Myelopathy (n = 5) 4 (80%) 1 (20%)
   Myeloneuropathy (n = 6) 1 (17%) 5 (83%)
   Peripheral Neuropathy (n = 6) 4 (67%) 2 (33%)
Non-CHIKV patients (n = 15) 8 (53%) 7 (47%)